Gish Biomedical Profit Rises 31%

IRVINE —  Gish Biomedical Inc., a medical device company, reported that net income rose 31% in the fiscal year ended June 30 to $1.7 million, or 52 cents a share, from $1.3 million, or 41 cents a share, for the prior year. Sales rose 2% to $21.6 million from $21.1 million.

Profit for the fourth quarter declined 8% to $399,000, or 12 cents a share, from $435,000, or 14 cents a share, for the same period a year ago. Sales were down 5% to $5.2 million from $5.5 million.